A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to discover how personality types may affect someone?s ability to learn and improve themselves. Specifically, learn and improve in a competition.
The purpose of this study is to examine the factors that contribute to greater or less success in listening comprehension for first and second language listeners. We are particularly interested in the effect of different speakers, and of your memory span on comprehension. The goal is to understand how people …
We are trying to determine the relationship between personality processes and psychophysiological activity, including such basic measures as hand temperature, skin moisture, heart rate, and respiration rate.
The purpose of this research study is to measure how well and how safe MEDI0457 vaccine in combination with Durvalumab is in treating patients with recurrent/metastatic human papilloma virus associated head and neck squamous cancer.
The purpose of this pilot study is to test the preliminary effects of a free-living physical activity intervention, STEPS to Enhance Physical Activity (STEPS), compared to usual care on fatigue (tiredness), functional ability (ability to perform tasks associated with daily living, like moving from a sitting to standing position), muscle …
The purpose of the “Dissecting the Genetic Contributions to Fetal Alcohol Spectrum Disorders” (DiG FASD) study is to understand how genetics affects FASD.
The purpose of this study is to help healthcare professionals better understand traumatic brain injury and the management of emotional problems. The purpose of this study is to examine how treatment program changes participants awareness and understanding of their emotions, and ability to control their emotions.
The purpose of this research study is to learn more about the safety and anti-cancer activity of a 3-drug combination therapy involving antibodies nivolumab, ipilimumab and panitumumab.